ACE and hydrops fetalis: For hemodynamically stable patients, the initiation of guideline-directed medical therapy (GDMT) for HF with reduced ejection fraction (HFrEF) is the mainstay, including beta-blockers and ACE inhibitors (or ARBs) [73,74].